Overview of Trientine Hydrochloride Capsule USP
Trientine Hydrochloride Capsule USP, marketed under the brand name TRIENTINE TAJ, is a specialized pharmaceutical formulation designed for the management of Wilson’s Disease, a genetic disorder characterized by abnormal copper accumulation in the body. Manufactured under stringent Good Manufacturing Practices (GMP), this formulation offers precise dosage accuracy, consistent quality, and proven therapeutic efficacy.
Product Name and Brand Identification
- Product Name: Trientine Hydrochloride Capsule USP
- Brand Name: TRIENTINE TAJ
- Strength: 250mg,300mg
- Dosage Form: Hard Gelatin Capsule
- Route of Administration: Oral
- Manufacturer: Taj Pharma India Ltd.
- Therapeutic Category: Antidote, Critical Care Medicine
Each capsule is formulated to deliver Trientine Hydrochloride, ensuring optimal copper chelation activity to support safe and effective treatment outcomes.
Qualitative and Quantitative Composition
Each Trientine Hydrochloride Capsule USP 250mg (TRIENTINE TAJ) contains:
- Active Ingredient: Trientine Hydrochloride USP equivalent to 250mg Trientine.
- Excipients: Q.S. (quantity sufficient) for formulation stability and bioavailability.
- Color: Approved colorants used in the capsule shell as per pharmacopeial standards.
This composition adheres strictly to USP specifications, ensuring pharmaceutical-grade purity, potency, and stability.
Pharmacological Classification and Mechanism of Action
Trientine Hydrochloride belongs to the pharmacological class of chelating agents. It functions by binding free copper ions in the body, forming stable complexes that are excreted primarily via the urine. This chelation process effectively reduces systemic copper levels, preventing accumulation in vital organs such as the liver, brain, and kidneys.
By restoring copper balance, Trientine helps alleviate symptoms of Wilson’s Disease, including hepatic dysfunction, neurological complications, and psychiatric disturbances.
Therapeutic Indications
TRIENTINE TAJ is indicated for the treatment of Wilson’s Disease (Hepatolenticular Degeneration).
This inherited metabolic disorder impairs copper excretion, leading to toxic accumulation. Trientine Hydrochloride is recommended for:
- Patients intolerant to Penicillamine, the first-line chelating agent.
- Long-term management of copper overload.
- Maintenance therapy after stabilization of copper levels.
Through its powerful chelating action, TRIENTINE TAJ helps protect organ function, improve neurological symptoms, and prevent disease progression.
Dosage and Administration
Dosage:
The dosage of Trientine Hydrochloride Capsules should be determined by a qualified physician, based on the patient’s age, weight, and severity of copper accumulation. The typical adult dosage may range from 750mg to 2g daily, divided into two to four doses.
Administration:
- Administer orally with water on an empty stomach (at least 1 hour before or 2 hours after meals).
- Avoid concurrent intake with food or supplements containing iron or zinc, as they may interfere with Trientine absorption.
- Capsules should be swallowed whole; do not chew or crush.
Duration of Therapy:
Wilson’s disease requires lifelong treatment; discontinuation or irregular dosing may lead to copper re-accumulation and severe complications.
Storage and Stability
Storage Conditions:
- Store in a cold environment between 2°C to 8°C, protected from moisture.
- Keep the container tightly closed to preserve potency and prevent degradation.
- Do not freeze.
Stability Studies:
Comprehensive stability testing has demonstrated product integrity throughout the labeled shelf life under recommended conditions, ensuring consistent therapeutic performance.
Regulatory Documentation and Compliance
Each batch of Trientine Hydrochloride Capsule USP is backed by a robust regulatory dossier including:
- Certificate of Analysis (COA)
- Method of Analysis (MOA)
- Certificate of Pharmaceutical Product (COPP)
- Free Sale Certificate (FSC)
- Stability Study Reports
- Good Manufacturing Practice (GMP) Certification
- CTD Dossier (Common Technical Document Format)
All documents comply with WHO, USFDA, MHRA, and EMA regulatory frameworks, supporting global registration and marketing authorizations.
Pharmaceutical Form and Packaging
Dosage Form: Hard Gelatin Capsule
Available Packaging Options:
- 30s (Bottle or Blister Pack)
- 90s (Commercial Pack)
- 100s (Bulk or Institutional Pack)
Each pack includes:
- Patient Information Leaflet (PIL) – Guidance for safe use and side effect management.
- Summary of Product Characteristics (SmPC) – Comprehensive data for healthcare professionals.
Packaging is designed to maintain product stability and facilitate patient convenience while meeting international labeling standards.
Caution and Warnings
CAUTION:
- Read the enclosed leaflet carefully before use.
- Keep out of reach of children.
- Swallow whole, do not chew or crush.
WARNING:
This medication is to be sold by retail on the prescription of a Registered Medical Practitioner only.
Pregnancy and Lactation:
Use during pregnancy or lactation should be assessed by a healthcare professional. Trientine should only be prescribed when the benefit outweighs the potential risk.
Drug Interactions:
Avoid co-administration with iron supplements, antacids, or zinc-containing products. Separate dosing by at least 2 hours to minimize absorption interference.
Adverse Reactions and Side Effects
Commonly reported side effects include:
- Gastrointestinal discomfort (nausea, vomiting, or abdominal pain)
- Headache or dizziness
- Skin rashes (rare)
- Iron deficiency anemia due to copper depletion
Monitoring Parameters:
Regular laboratory evaluations are essential to monitor:
- Serum copper and ceruloplasmin levels
- Urinary copper excretion
- Liver function tests (LFTs)
Prompt medical evaluation is necessary for any severe or persistent adverse effects.
Pharmacokinetics
- Absorption: Rapid absorption following oral administration on an empty stomach.
- Distribution: Primarily binds to copper in plasma and tissues.
- Metabolism: Minimal hepatic metabolism.
- Excretion: Copper-Trientine complexes are excreted mainly through urine.
This pharmacokinetic profile ensures effective systemic copper removal with minimal accumulation or toxicity risk.
Clinical Benefits of TRIENTINE TAJ
- Effective Copper Chelation: Provides sustained reduction in body copper levels.
- Safe Alternative to Penicillamine: Well-tolerated in patients with penicillamine sensitivity.
- High Therapeutic Efficacy: Proven clinical results in improving hepatic and neurological outcomes.
- Global Quality Assurance: Manufactured under strict GMP and quality control standards.
Trientine Hydrochloride Capsule USP (TRIENTINE TAJ) represents a reliable, high-quality therapeutic option for managing Wilson’s Disease. Developed and manufactured by Taj Pharma India Ltd., this formulation embodies excellence in pharmaceutical research, regulatory compliance, and patient safety. With its consistent copper-chelating efficacy, global documentation support, and precision manufacturing, TRIENTINE TAJ continues to be a trusted choice for healthcare professionals worldwide.